Abstract
Aim
Longitudinal course and genotype-phenotype correlation in patients and carriers with heterozygous mutations in hBEST1 (bestrophin).
Methods
Thirteen patients and seven possible carriers were characterised by mutation analysis with SSCPA and direct sequencing, clinical examination and fundus autofluorescence (AF). Electrophysiology (EOG and mfERG) and optical coherence tomography (OCT) were additionally performed whenever possible.
Results
We identified seven different heterozygous mutations in ten unrelated families with Best disease. I296del was the most frequent mutation. Five of nine individuals with I295del and two of three with N99K were asymptomatic carriers. One patient with I295del mutation had funduscopically unilateral Best disease. In three children (all with I295del), EOG initially showed a clearly present light peak that deteriorated during 5 years of follow-up in two of them. Increased AF corresponded well to funduscopically visible lesions. During 3–6 years of follow-up, the lesion area did not change significantly, but there were obvious changes in the inner structure of the lesion.
Conclusion
In the present series I295del, the most frequent mutation in our study, and N99K showed reduced penetrance. EOG was normal in young patients even if prime signs were visible. The lesion area did not depend on the mutation and did not correlate with VA. Lower VA was associated with a more irregular AF pattern due to scarring or haemorrhage. Our results indicate a disease causing effect that is cumulative over time.
This is a preview of subscription content, access via your institution.






References
Baca W, Fishman GA, Alexander KR, Glenn AM (1994) Dark adaptation in patients with Best vitelliform macular dystrophy. Br J Ophthalmol 78:430–432
Bard LA, Cross HE (1975) Genetic counseling of families with Best macular dystrophy. Trans Am Acad Ophthalmol Otolaryngol 79:OP865–OP873
Best F (1905) Über eine hereditäre Maculaaffektion. Z Augenheik 13:199–212
Birndorf LA, Dawson WW (1973) A normal electrooculogram in a patient with a typical vitelliform macular lesion. Invest Ophthalmol 12:830–833
Chung JE, Spaide RF (2004) Fundus autofluorescence and vitelliform macular dystrophy. Arch Ophthalmol 122:1078–1079
Clemett R (1991) Vitelliform dystrophy: long-term observations on New Zealand pedigrees. Aust N Z J Ophthalmol 19:221–227
Cross HE, Bard L (1974) Electro-oculography in Best’s macular dystrophy. Am J Ophthalmol 77:46–50
Deutman AF (1989) Macular dystrophies. In: Schachat AP, Murphy RP, Patz A (eds) II. Medical retina. Mosby, St Louis pp 243–300
Fishman GA, Baca W, Alexander KR, Derlacki DJ, Glenn AM, Viana M (1993) Visual acuity in patients with best vitelliform macular dystrophy. Ophthalmology 100:1665–1670
Francois J, De Rouck A, Fernandez-Sasso D (1967) Electro-oculography in vitelliform degeneration of the macula. Arch Ophthalmol 77:726–733
Frangieh GT, Green WR, Fine SL (1982) A histopathologic study of Best’s macular dystrophy. Arch Ophthalmol 100:1115–1121
Gass JDM (1997) Heredodystrophic disorders affecting the pigment epithelium and retina. In: Steroscopic atlas of macular disease—diagnosis and treatment) Mosby, St Louis pp 303–436
Gerth C, Andrassi-Darida M, Bock M, Preising MN, Weber BH, Lorenz B (2002) Phenotypes of 16 Stargardt macular dystrophy/fundus flavimaculatus patients with known ABCA4 mutations and evaluation of genotype-phenotype correlation. Graefe's Arch Clin Exp Ophthalmol 240:628–638
Hood DC, Frishman LJ, Saszik S, Viswanathan S (2002) Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci 43:1673–1685
Huang D, Swanson EA, Lin CP et al (1991) Optical coherence tomography. Science 254:1178–1181
Jarc-Vidmar M, Kraut A, Hawlina M (2003) Fundus autofluorescence imaging in Best’s vitelliform dystrophy. Klin Monatsbl Augenheilkd 220:861–867
Lorenz B, Wabbels B, Wegscheider E, Hamel CP, Drexler W, Preising MN (2004) Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65. Ophthalmology 111:1585–1594
Marmor MF (1998) Standardization notice: EOG standard reapproved. Electro-oculogram. Doc Ophthalmol 95:91–92
Marmor MF, Zrenner E (1993) Standard for clinical electro-oculography. International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol 85:115–124
Marmor MF, Zrenner E (1998) Standard for clinical electroretinography (1999 update). International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol 97:143–156
Marmor MF, Zrenner E (1999) Standard for clinical electroretinography (1998 update). Doc Ophthalmol 97:143–156
Marmorstein AD, Marmorstein LY, Rayborn M, Wang X, Hollyfield JG, Petrukhin K (2000) Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci USA 97:12758–12763
Marquardt A, Stöhr H, Passmore LA, Kramer F, Rivera A, Weber BH (1998) Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best’s disease). Hum Mol Genet 7:1517–1525
Miller SA (1978) Fluorescence in Best’s vitelliform dystrophy, lipofuscin, and fundus flavimaculatus. Br J Ophthalmol 62:256–260
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Mohler CW, Fine SL (1981) Long-term evaluation of patients with Best’s vitelliform dystrophy. Ophthalmology 88:688–692
O’Gorman S, Flaherty WA, Fishman GA, Berson EL (1988) Histopathologic findings in Best’s vitelliform macular dystrophy. Arch Ophthalmol 106:1261–1268
Petrukhin K, Koisti MJ, Bakall B et al (1998) Identification of the gene responsible for Best macular dystrophy. Nat Genet 19:241–247
Pianta MJ, Aleman TS, Cideciyan AV et al (2003) In vivo micropathology of Best macular dystrophy with optical coherence tomography. Exp Eye Res 76:203–211
Pollack K, Kreuz FR, Pillunat LE (2005) Morbus Best mit normalem EOG-Fallvorstellung einer familiären Makuladystrophie. Ophthalmologe 102:891–894
Puliafito CA, Hee MR, Schuman JS, Fujimoto JG (1995) Optical coherence tomography of ocular disease. Slack Inc., Thorofare, New Jersey
Qu Z, Wei RW, Mann W, Hartzell HC (2003) Two bestrophins cloned from Xenopus laevis oocytes express Ca(2+)-activated Cl(−) currents. J Biol Chem 278:49563–49572
Seddon JM, Sharma S, Chong S, Hutchinson A, Allikmets R, Adelman RA (2003) Phenotype and genotype correlations in two Best families. Ophthalmology 110:1724–1731
Strauss O, Rosenthal R (2005) Funktion des Bestrophins. Ophthalmologe 102:122–126
Sun H, Tsunenari T, Yau KW, Nathans J (2002) The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci USA 99:4008–4013
Tsunenari T, Sun H, Williams J et al (2003) Structure-function analysis of the bestrophin family of anion channels. J Biol Chem 278:41114–41125
von Rückmann A, Fitzke FW, Bird AC (1997) In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol 115:609–615
Weingeist TA, Kobrin JL, Watzke RC (1982) Histopathology of Best’s macular dystrophy. Arch Ophthalmol 100:1108–1114
Acknowledgements
This study was supported by grants from Deutsche Forschungsgemeinschaft (DFG Lo 457/3, DFG Lo457/5). The authors would like to thank all patients and their families for participating in the study, Christoph Friedburg, MD for fruitful discussions on electrophysiological recordings, Renate Foeckler for excellent technical assistance, Martin Rosner, Roman Miedl and Günther Schuch for OCT, fundus and AF imaging and Birgit Langer and Ulla Biendl for electrophysiological recordings.
Author information
Authors and Affiliations
Corresponding author
Additional information
B. Wabbels and M. N. Preising contributed equally in this work.
Proprietary Interest Statement: The authors do not have any financial interest in the methods or equipment reported in this manuscript.
Rights and permissions
About this article
Cite this article
Wabbels, B., Preising, M.N., Kretschmann, U. et al. Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy. Graefe's Arch Clin Exp Ophthalmo 244, 1453–1466 (2006). https://doi.org/10.1007/s00417-006-0286-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-006-0286-6
Keywords
- Bestrophin
- Juvenile vitelliform macular dystrophy
- Longitudinal course
- Optical coherence tomography
- Electrooculogram
- Fundus autofluorescence